Technical Analysis for ABBV - AbbVie Inc.

Grade Last Price % Change Price Change
grade B 87.71 -1.00% -0.89
ABBV closed down 1.0 percent on Thursday, December 13, 2018, on 60 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical ABBV trend table...

Date Alert Name Type % Chg
Dec 13 20 DMA Resistance Bearish 0.00%
Dec 13 Fell Below 50 DMA Bearish 0.00%
Dec 12 20 DMA Resistance Bearish -1.00%
Dec 12 Crossed Above 50 DMA Bullish -1.00%
Dec 12 NR7 Range Contraction -1.00%
Dec 12 Multiple of Ten Bearish Other -1.00%
Dec 12 Up 3 Days in a Row Strength -1.00%
Dec 11 20 DMA Resistance Bearish -0.52%
Dec 11 50 DMA Resistance Bearish -0.52%
Dec 10 MACD Bearish Signal Line Cross Bearish 0.11%

Older signals for ABBV ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AbbVie Inc., a research-based biopharmaceutical company, engages in the discovery, development, manufacture, and sale of pharmaceutical products worldwide. Its product portfolio includes a range of adult and pediatric pharmaceuticals, including HUMIRA, a biologic therapy administered as a subcutaneous injection to treat various autoimmune diseases; Synthroid used in the treatment of hypothyroidism; AndroGel, a daily testosterone replacement therapy; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Kaletra, a prescription anti-HIV-1 medicine used with other anti-HIV-1 medications to increase the chance of treatment response in people with HIV-1; and Lupron, a product for the palliative treatment of advanced prostate cancer. The company also offers TriCor and TRILIPIX, which are fibric acid derivatives that are indicated as adjuncts to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels; Niaspan, an extended release form of niacin that is indicated as an adjunct to diet to reduce total cholesterol, LDL cholesterol, and triglyceride levels, as well as to increase HDL cholesterol levels; Synagis, which protects at-risk infants from severe respiratory disease or respiratory syncytial virus; Sevoflurane, an anesthesia product for human use; Duodopa, a levodopa-carbidopa intestinal gel used to treat advanced Parkinson's disease; and Zemplar used for the prevention and treatment of secondary hyperparathyroidism. It sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. The company has collaboration with Alvine Pharmaceuticals, Inc. to develop a oral treatment for patients with celiac disease. AbbVie Inc. was incorporated in 2012 and is based in North Chicago, Illinois. As of January 01, 2013.AbbVie Inc. operates independently of Abbott Laboratories.
Is ABBV a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 125.86
52 Week Low 77.5
Average Volume 6,709,600
200-Day Moving Average 95.5763
50-Day Moving Average 87.9326
20-Day Moving Average 88.998
10-Day Moving Average 89.777
Average True Range 2.8743
ADX 14.5
+DI 23.2011
-DI 25.4161
Chandelier Exit (Long, 3 ATRs ) 86.3571
Chandelier Exit (Short, 3 ATRs ) 93.22289999999999
Upper Bollinger Band 93.4963
Lower Bollinger Band 84.4997
Percent B (%b) 0.36
BandWidth 10.108766
MACD Line 0.2624
MACD Signal Line 0.49
MACD Histogram -0.2276
Fundamentals Value
Market Cap 139.82 Billion
Num Shares 1.59 Billion
EPS 4.07
Price-to-Earnings (P/E) Ratio 21.55
Price-to-Sales 5.35
Price-to-Book 23.76
PEG Ratio 1.00
Dividend 2.56
Dividend Yield 2.92%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 91.64
Resistance 3 (R3) 91.96 90.98 90.99
Resistance 2 (R2) 90.98 89.98 90.82 90.77
Resistance 1 (R1) 89.34 89.36 88.85 89.02 90.55
Pivot Point 88.36 88.36 88.11 88.20 88.36
Support 1 (S1) 86.72 87.36 86.23 86.40 84.87
Support 2 (S2) 85.74 86.74 85.58 84.65
Support 3 (S3) 84.10 85.74 84.44
Support 4 (S4) 83.78